VICTORIA FORTH: Open Payments
NPI 1780086066 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,396 in 62 payments from 6 companies in 2025. Trend: 2023 $482 · 2024 $3,241 · 2025 $3,396
Food & beverage: $2,652Consulting: $744
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $1,497 |
| AstraZeneca Pharmaceuticals LP | 35 | $1,408 |
| Amgen Inc. | 13 | $258 |
| Verona Pharma, Inc. | 1 | $137 |
| Pulmonx Corporation | 1 | $79 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: TEZSPIRE, DUPIXENT, Ohtuvayre, FASENRA, BREZTRI, AIRSUPRA, LUMIZYME, CHARTIS CATHETER.
Industry payments across MA — which companies pay providers there.
